In addition, Cav-1 was reported to be involved in the anti-cancer activity of Res in a human hepatocellular carcinoma (HCC) model [17], while limited data existed regarding the modulation of Res on endothelial permeability through Cav-1 in vitro and in vivo. The gene discussed is CAV1; the disease is hepatocellular carcinoma.